|
1
|
Swartz MA, Iida N, Roberts EW, Sangaletti
S, Wong MH, Yull FE, Coussens LM and DeClerck YA: Tumor
microenvironment complexity: Emerging roles in cancer therapy.
Cancer Res. 72:2473–2480. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Martin FT, Dwyer RM, Kelly J, Khan S,
Murphy JM, Curran C, Miller N, Hennessy E, Dockery P, Barry FP, et
al: Potential role of mesenchymal stem cells (MSCs) in the breast
tumour microenvironment: Stimulation of epithelial to mesenchymal
transition (EMT). Breast Cancer Res Treat. 124:317–326. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X,
Gong W, Han ZB, Xu ZS, Lu YX, Liu D, et al: Isolation and
characterization of human umbilical cord mesenchymal stem cells
with hematopoiesis-supportive function and other potentials.
Haematologica. 91:1017–1026. 2006.PubMed/NCBI
|
|
4
|
Prockop DJ, Sekiya I and Colter DC:
Isolation and characterization of rapidly self-renewing stem cells
from cultures of human marrow stromal cells. Cytotherapy.
3:393–396. 2001. View Article : Google Scholar
|
|
5
|
In't Anker PS, Scherjon SA, Kleijburg-van
der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE and Kanhai HH:
Isolation of mesenchymal stem cells of fetal or maternal origin
from human placenta. Stem Cells. 22:1338–1345. 2004. View Article : Google Scholar
|
|
6
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deans RJ and Moseley AB: Mesenchymal stem
cells: Biology and potential clinical uses. Exp Hematol.
28:875–884. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen J, Zhang ZG, Li Y, Wang L, Xu YX,
Gautam SC, Lu M, Zhu Z and Chopp M: Intravenous administration of
human bone marrow stromal cells induces angiogenesis in the
ischemic boundary zone after stroke in rats. Circ Res. 92:692–699.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Spaeth E, Klopp A, Dembinski J, Andreeff M
and Marini F: Inflammation and tumor microenvironments: Defining
the migratory itinerary of mesenchymal stem cells. Gene Ther.
15:730–738. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hombauer H and Minguell JJ: Selective
interactions between epithelial tumour cells and bone marrow
mesenchymal stem cells. Br J Cancer. 82:1290–1296. 2000. View Article : Google Scholar
|
|
11
|
Fierro FA, Sierralta WD, Epuñan MJ and
Minguell JJ: Marrow-derived mesenchymal stem cells: Role in
epithelial tumor cell determination. Clin Exp Metastasis.
21:313–319. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cho JA, Park H, Lim EH, Kim KH, Choi JS,
Lee JH, Shin JW and Lee KW: Exosomes from ovarian cancer cells
induce adipose tissue-derived mesenchymal stem cells to acquire the
physical and functional characteristics of tumor-supporting
myofibroblasts. Gynecol Oncol. 123:379–386. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Karnoub AE, Dash AB, Vo AP, Sullivan A,
Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R and Weinberg
RA: Mesenchymal stem cells within tumour stroma promote breast
cancer metastasis. Nature. 449:557–563. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vergara D, Merlot B, Lucot JP, Collinet P,
Vinatier D, Fournier I and Salzet M: Epithelial-mesenchymal
transition in ovarian cancer. Cancer Lett. 291:59–66. 2010.
View Article : Google Scholar
|
|
15
|
Lei X, Wang L, Yang J and Sun LZ: TGFbeta
signaling supports survival and metastasis of endometrial cancer
cells. Cancer Manag Res. 2009:15–24. 2009.PubMed/NCBI
|
|
16
|
Imamura T, Hikita A and Inoue Y: The roles
of TGF-β signaling in carcinogenesis and breast cancer metastasis.
Breast Cancer. 19:118–124. 2012. View Article : Google Scholar
|
|
17
|
Spaeth EL, Dembinski JL, Sasser AK, Watson
K, Klopp A, Hall B, Andreeff M and Marini F: Mesenchymal stem cell
transition to tumor-associated fibroblasts contributes to
fibrovascular network expansion and tumor progression. PLoS One.
4:e49922009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Do TV, Kubba LA, Du H, Sturgis CD and
Woodruff TK: Transforming growth factor-beta1, transforming growth
factor-beta2, and transforming growth factor-beta3 enhance ovarian
cancer metastatic potential by inducing a Smad3-dependent
epithelial-to-mesenchymal transition. Mol Cancer Res. 6:695–705.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Stagg J: Mesenchymal stem cells in cancer.
Stem Cell Rev. 4:119–124. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shinagawa K, Kitadai Y, Tanaka M, Sumida
T, Kodama M, Higashi Y, Tanaka S, Yasui W and Chayama K:
Mesenchymal stem cells enhance growth and metastasis of colon
cancer. Int J Cancer. 127:2323–2333. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Albarenque SM, Zwacka RM and Mohr A: Both
human and mouse mesenchymal stem cells promote breast cancer
metastasis. Stem Cell Res (Amst). 7:163–171. 2011. View Article : Google Scholar
|
|
22
|
Lee MY and Shen MR: Epithelial-mesenchymal
transition in cervical carcinoma. Am J Transl Res. 4:1–13.
2012.PubMed/NCBI
|
|
23
|
Castilla MÁ, Moreno-Bueno G, Romero-Pérez
L, Van De Vijver K, Biscuola M, López-García MÁ, Prat J,
Matías-Guiu X, Cano A, Oliva E, et al: Micro-RNA signature of the
epithelial-mesenchymal transition in endometrial carcinosarcoma. J
Pathol. 223:72–80. 2011. View Article : Google Scholar
|
|
24
|
Francí C, Takkunen M, Dave N, Alameda F,
Gómez S, Rodríguez R, Escrivà M, Montserrat-Sentís B, Baró T,
Garrido M, et al: Expression of Snail protein in tumor-stroma
interface. Oncogene. 25:5134–5144. 2006.PubMed/NCBI
|
|
25
|
Hogan NM, Dwyer RM, Joyce MR and Kerin MJ:
Mesenchymal stem cells in the colorectal tumor microenvironment:
Recent progress and implications. Int J Cancer. 131:1–7. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Morel AP, Lièvre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sullivan NJ, Sasser AK, Axel AE, Vesuna F,
Raman V, Ramirez N, Oberyszyn TM and Hall BM: Interleukin-6 induces
an epithelial-mesenchymal transition phenotype in human breast
cancer cells. Oncogene. 28:2940–2947. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yadav A, Kumar B, Datta J, Teknos TN and
Kumar P: IL-6 promotes head and neck tumor metastasis by inducing
epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling
pathway. Mol Cancer Res. 9:1658–1667. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen P and Parks WC: Role of matrix
metalloproteinases in epithelial migration. J Cell Biochem.
108:1233–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zeng ZS, Cohen AM and Guillem JG: Loss of
basement membrane type IV collagen is associated with increased
expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during
human colorectal tumorigenesis. Carcinogenesis. 20:749–755. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Thomas GT, Lewis MP and Speight PM: Matrix
metalloproteinases and oral cancer. Oral Oncol. 35:227–233. 1999.
View Article : Google Scholar
|
|
32
|
Kishimoto T: Interleukin-6: Discovery of a
pleiotropic cytokine. Arthritis Res Ther. 8(Suppl 2): S22006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Duan Z, Foster R, Bell DA, Mahoney J,
Wolak K, Vaidya A, Hampel C, Lee H and Seiden MV: Signal
transducers and activators of transcription 3 pathway activation in
drug-resistant ovarian cancer. Clin Cancer Res. 12:5055–5063. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shah K: Mesenchymal stem cells engineered
for cancer therapy. Adv Drug Deliv Rev. 64:739–748. 2012.
View Article : Google Scholar :
|
|
35
|
Sasser AK, Sullivan NJ, Studebaker AW,
Hendey LF, Axel AE and Hall BM: Interleukin-6 is a potent growth
factor for ER-alpha-positive human breast cancer. FASEB J.
21:3763–3770. 2007. View Article : Google Scholar : PubMed/NCBI
|
